NOTCH1 and B-cell chronic lymphocytic leukemia: Like SERCA inhibitors, bepridil blocked Notch1 maturation, reduced Notch1 activation, did not influence Notch2 expression, and, consistent with its mechanism of action, reduced ER Ca2+ pool in CLL [264].